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Abstract: We report a simple, sensitive and selective method for the colorimetric detection of 
serotonin (5-HT) in aqueous media using bifunctionalized gold nanoparticles (AuNPs). The 
probe (1) consisted of AuNPs functionalised with dithiobis(succinimidylpropionate) (DSP) and N-
acetyl-L-cysteine (NALC). DSP was chosen to react with the amino group of 5-HT, whereas 
NALC was chosen to bind the hydroxyl group in 5-HT through hydrogen bonding and 
electrostatic interactions. A double interaction between nanoparticles and the hydroxyl and the 
amino group of serotonin led to interparticle-crosslinking aggregation. This, resulted in a colour 
change from red to blue that can be observed by the naked eye. The probe was selective to 5-











dopamine, epinephrine, norepinephrine), selected biomolecules (i.e. L-tyrosine, gamma-
aminobutyric acid, L-cysteine, uric acid, oxalic acid, aspartic acid and glutamic acid) and 
common inorganic species. A limit of detection as low as 0.1 µM was determined in buffered 
water at pH 7 by UV-vis titrations. Similar response of the probe to 5-HT was observed in 
simulated blood serum, with a limit of detection of 0.12 µM, and a linear response within the 0-3 
µM concentration range, which is within the range of the 5-HT concentrations of clinical interest. 
Finally, the performance of probe (1) in real human blood samples was evaluated, and showed 
a remarkable ability to distinguish between normal 5-HT levels and 5-HT levels indicative of 
disease.  
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1. Introduction 
Serotonin (5-hydroxytryptamine, 5-HT), commonly known as the molecule of happiness, 
is an important neurotransmitter that plays a key role in the regulation of various cognitive and 
behavioural functions such as sleep, mood, pain, anxiety, appetite control, sexual activity and 
learning [1].  Serotonin is produced in several locations including the brain, to transport 
information along the central nervous system, and also in the gastrointestinal track (GIT) to 
regulate intestinal movement [2-3]. Abnormal 5-HT levels have been related with a number of 
disorders like depression, migraines, ADHD, autism and inflammatory syndromes [4-5]. 
Moreover, carcinoid tumours, which usually start in the GI tract, secrete large amounts of 5-HT. 
This leads to high 5-HT levels in the blood of patients and causes flushing of the skin, diarrhoea 
and breathing problems. In fact, evaluating 5-HT blood levels, together with 5-
hydroxyindoleacetic acid (a metabolite of 5-HT), is the principal laboratory test to diagnose 
carcinoid syndrome [6-7]. Although how the serotoninergic system operates exactly is still not 
well-known, scientists are attempting to elucidate the possible hormonal role of serotonin in 
neurodegenerative disorders like Parkinson’s [8-9] and Alzheimer’s disease [10]. All these 












In this scenario, the development of methods to detect 5-HT is a field of interest. 
Reported methods for 5-HT detection include liquid chromatography [11-17] and 
electrochemical techniques [18-24]. For example, the oxidation/reduction of 5-HT and dopamine 
using modified glassy carbon electrodes has been reported as a suitable electrochemical 
approach for 5-HT detection [23-24]. Enzymatic [25] and solid surface-room temperature 
phosphorescence assays have also been reported [26]. Other reported methods include 
fluorometric [27-29], flow cytometry [30], immunocytochemical and immunohistochemical [31-
33] techniques. Although most of these methods can accurately measure 5-HT, they require 
sophisticated high cost equipment and are time-consuming (especially liquid chromatography). 
However, designing simple procedures to detect 5-HT remains a challenge due to the 
complexity of the molecule and common interference from other neurotransmitters with similar 
chemical structures such as dopamine and epinephrine. 
As an alternative to traditional instrumental methods, chromogenic probes offer certain 
advantages as they are usually cheap, easy to use, require simple instrumentation or not 
instrumentation at all, and allow in situ and at-site detection [34]. An appealing approach to 
develop colorimetric probes is to use gold nanoparticles (AuNPs) given their unique 
optoelectronic properties [35-37]. When using AuNPs, the detection strategy is usually based on 
colour changes that arise from interparticle plasmon coupling during analyte-induced 
aggregation of nanoparticles. It is known that the red colour of dispersed AuNPs of a certain 
size turns dark blue upon aggregation, and this colour change can usually be observed by the 
naked eye, even at very low analyte concentrations [38-43]. For instance, Tian and co-workers 
have reported the use of functionalised AuNPs for the colorimetric detection of dopamine. A 
double interaction between the nanoparticles and the diol and the amino group of dopamine 
triggered the aggregation of AuNPs that results in a clear colour modulation [44]. 
For all the above reasons, and given our current interest in developing probes to detect 
bio-relevant molecules, we report herein a simple, sensitive and selective method for the 
colorimetric detection of 5-HT using bifunctionalised AuNPs. The recognition paradigm is shown 
in Scheme 1. Probe (1) consists of AuNPs of ca. 15 nm, which were functionalised 
dithiobis(succinimidylpropionate) (DSP) and N-acetyl-L-cysteine (NALC). DSP was chosen as a 











plays a double role: (i) it acts as a stabiliser for AuNPs thanks to its negative charge at a neutral 
pH; (ii) is also able to bind the hydroxyl group in 5-HT through hydrogen bonding and 
electrostatic interactions [46]. Whereas, functionalised AuNPS 1 would not aggregate, we 
expected the double interaction between 5-HT and 1 to lead to interparticle-crosslinking 





Scheme 1. Sensing paradigm of the colorimetric detection of serotonin (5-HT) based on gold nanoparticles 
bifunctionalised with NALC and DSP (probe 1). 
2. Experimental 
2.1. Chemicals 
Chloroauric acid (HAuCl4·3H2O), sodium citrate dihydrate, N-acetyl-L-cysteine (NALC), dithiobis 











norepinephrine (NE), L-tyrosine (L-Tyr), gamma-aminobutyric acid (GABA), uric acid (AU), 
oxalic acid (AO), aspartic acid (A.A) and glutamic acid (GA) were commercially available, and 
were used without purification. 
2.2. General Methods 
UV-Vis absorption spectra were recorded using a 1-cm path length quartz cuvette on a 
Shimadzu UV-2101PC spectrophotometer. All the measurements were taken at room 
temperature. To verify the serotonin-induced aggregation of the gold nanoparticles probe, high-
resolution transmission electron microscopy (JEOL-1010 transmission electron microscopy 
operating at 100 kV) was used. Z potential and hydrodynamic diameter values were measured 
in a Malvern Zetasizer ZS 3 times in 10-25 cycles. Fourier-transform infrared spectroscopy 
spectra were recorded with a Cary 630 FT-IR spectrometer within the wavenumber range of 
648-4000cm-1 at a resolution of 8 cm-1. Proton nuclear magnetic resonance spectroscopy (1H-
NMR) spectra were recorded with a Bruker DRX-500 Spectrometer (500 MHz, 1024 scans).  
2.3. Synthesis of citrate-capped AuNPs 
Citrate-capped AuNPs with a diameter ca. 15 nm, were synthesised as previously reported [46]. 
Briefly, 5 mL of aqueous 13.61 mM trisodium citrate solution were added to an aqueous boiling 
solution of HAuCl4 (95 mL, 0.23 mM) and the resulting solution was allowed to boil for 30 min 
until a red solution was obtained. The solution was cooled to room temperature. Then the 
mixture was purified by filtering through a 0.22 µM membrane and the filtrate was stored in a 
refrigerator at 4°C until it was used. 
2.4. Functionalisation of AuNPs 
Probe 1 was prepared by modifying the citrate-capped AuNPs by ligand-exchange reaction, 
which was performed at room temperature by mixing 95 mL of the as-prepared AuNPs with 190 
µL of 2 mM aqueous solution of NALC and 190 µL of DSP (2 mM in DMF). Ligands were added 
simultaneously and the solution was stirred for 1 h with magnetic stirring. To purify 1, the 
mixture was centrifuged for 10 min at 11,000 rpm and the supernatants were decanted twice. 











For the sensing studies, serotonin solutions were freshly prepared in 50 mM Tris buffer, pH 7.0, 
at room temperature. Next 500 μL of 1 (4.37 x 10-10 M) and 500 μL of the 5-HT solution at an 
appropriate concentration were placed to obtain a final volume of 1 mL. Samples were 
incubated for 3 min before taking measurements in the spectrophotometer. The procedure was 
the same for the interferences. Simulated blood serum (SBS) [47] was prepared as follows: 
8.036 g of NaCl, 0.352 g NaHCO3, 0.225 g of KCl, 0.230 g of K2HPO4·3H2O, 0.311 g 
MgCl2·6H2O, 40 mL of HCl 1M, 0.293 g of CaCl2, 0.072 g of Na2SO4 and 6.063 g of Tris were all 
dissolved in 1 L of miliQ water and adjusted to pH 7.4. Next 100 mL of this solution and 900 mL 
of miliQ water were used to prepare the corresponding SBS solutions of 5-HT. Then 500 μL of 1 
were mixed with 500 μL of SBS solutions of 5-HT at an appropriate concentration, incubated for 
3 min, and analysed by UV-vis spectrophotometry. Real human blood samples from a healthy 
volunteer were obtained thanks to the support of our university health centre. Firstly, red blood 
cells were separated from serum by centrifugation. Next, serum samples were further 
centrifuged (15 min, 11000 rpm) using Amicon Ultra-05 centrifugal filters units with Ultracel-10 
membranes to remove proteins, and were mixed (1:1) with 50 mM Tris Buffer. Finally, 100 μL of 
1 and 100 μL of the resulting serum samples (which either contained spiked 5-HT or did not) 
were incubated for 3 min and measured in the spectrophotometer (see the illustrated steps in 
Figure S13). 
3. Results and Discussion 
In order to prepare probe 1, the citrate-stabilised AuNPs were firstly obtained following 
the Turkevich-Frens method, by reducing tetrachloroauric acid with trisodium citrate in boiling 
water [48-50].  Then, citrate was displaced from the surface of the nanoparticles in a ligand-
exchange reaction by the simultaneous addition of NALC and DSP (1:1 molar ratio). Finally, the 
functionalised AuNPs 1 were purified by repeated centrifugation and redispersion in water. 
The resulting bifunctionalised AuNPs were characterised by UV-Vis, transmission 
electron microscopy (TEM), dynamic light scattering (DLS), Fourier-transform infrared 
spectroscopy (FTIR) and proton nuclear magnetic resonance spectroscopy (1H-NMR) studies. 
The monodisperse bifunctionalised nanoparticles (1) were obtained with an average size of 15 
nm as determined by TEM (Figure S1). The aqueous suspensions of 1 were red wine-coloured 











typical colour and SPR band shown by those AuNPs smaller than 25 nm [51-52]. Typical 
concentrations of final probe 1 were calculated by UV-vis spectroscopy to be ca. 8.74 x 10-10 M 
from an estimated molar extinction coefficient of ε = 3.97 x 108 M-1 cm-1 [53]. The FTIR studies 
showed the appearance of absorption bands which were attributed to NALC (C=O stretching at 
1649 cm−1, N-H bending at 1543 cm−1 and N-H stretching  at 3352 cm−1), as reported in other 
studies [54], and DSP’s C=O stretching also appeared at 1720 cm−1 [55] (see Figure S3). 1H-
NMR spectra also showed the appearance of signals, which were attributed to the 
functionalisation with NALC and DSP. (see Figure S4). The red wine-coloured aqueous 
dispersions of 1 remained stable in the refrigerator for more than 1 month, and no changes 
were observed on the characteristic plasmon absorption band. 
In order to evaluate the sensing capabilities of the prepared nanoparticles, buffered 
aqueous suspensions of 1 at pH 7.0 (Tris, 50 mM) were studied in the absence and presence of 
5-HT (100 µM). Whereas the suspension of the nanoparticles remained red in the absence of 5-
HT, addition of 5-HT induced a remarkable shift of the surface plasmon absorption from 521 nm 
to 605 nm, which resulted in a colour change from red to blue that could be observed by the 
naked eye, and indicated aggregation of AuNPs (see Figure 1). Aggregation of nanoparticles 
was not only confirmed by the instantaneous colour change, but also by TEM (vide infra) and 
DLS (see Figure S2). From the latter, it was found that the hydrodynamic diameter of the 
nanoparticles increased from 16.5 nm for 1 to 704 nm when 5-HT was added. The zeta 
potential reduced from -17.8 mV (1) to -6.14 mV (1+5-HT). 
 











In another step, the selectivity of the prepared functionalised AuNPs towards 5-HT was 
evaluated. The response of 1 in the presence of other neurotransmitters, e.g., dopamine (DA), 
epinephrine (Epy) and norepinephrine (NE), and of other biomolecules, e.g., L-tyrosine (L-Tyr, a 
precursor for stimulatory neurotransmitters), gamma-aminobutyric acid (GABA, an inhibitory 
neurotransmitter), L-cysteine (L-Cys), aspartic acid (AA) and glutamic acid (GA) (excitatory 
amino acids), uric acid (UA, described recently as a potential neurotransmitter) and oxalic acid 
(OA) was studied. Whereas a remarkable colour change was observed in the presence of 5-HT, 
negligible colour modulations and negligible changes in the A605/A521 ratio (A605 = absorbance at 
605 nm, A521 = absorbance at 521 nm) were observed upon the addition of potential interferents 
(see Figure 2a and 2b and Figure S5). In an additional competitive experiment, the response of 
1 in a mixture that contained 5-HT and DA, Epy, NE, L-Tyr, GABA, L-Cys, UA, OA, AA and GA 
(500 µM of each) was also tested. As seen in Figure 2b, the observed response was extremely 
similar to that found when probe 1 was used alone with 5-HT. All these data indicate that the 
bifunctionalised AuNPs 1 are able to selectively detect 5-HT in buffered media, and in the 
presence of other neurotransmitters and selected biomolecules. One possible explanation for 
the good selectivity for 5-HT versus catecholamines (dopamine, epinephrine and 
norepinephrine) could be the different ionisation equilibria of the biogenic phenolic amines and 
catecholamines in biological media, with different proportions of zwitterionic species [55-56]. 
The selectivity of the probe in the presence of common inorganic cations and anions was also 
tested. Probe 1 remained stable in the presence of the different species individually and in a 
mixture that contained them all. Remarkably, the probe retained its capability to recognise 5-HT 













Figure 2. Response of 1 in the presence of different molecules (500 µM) at pH 7.0 (Tris, 50mM). a) Vials with the 
different tested molecules. b) Representation of A605/A521 for interferences. 
 
Furthermore, the sensitivity of 1 to 5-HT was evaluated. In this experiment, the colour 
changes of aqueous suspensions of 1 in the presence of different amounts of 5-HT were 
studied. As seen in Figure 3, a gradual colour modulation from red wine to purple, and finally to 
blue, which was dependent on the 5-HT concentration, was observed. This change coincides 
with the proposed sensing protocol that involves the 5-HT-induced aggregation of the 
bifunctionalised AuNPs. The changes in colour shown in Figure 3a agree with changes in the 
UV-vis bands observed for the different prepared suspensions of 1 in the presence of increasing 
amounts of 5-HT (see Figure 3b). An increase in the aggregation of AuNPs, according to the 5-
HT concentration, was confirmed by the TEM studies (see Figure 3c). From the A605/A521 vs. 5-
HT concentration plot, a linear response within the 0-1 µM 5-HT concentration range was noted. 
From these studies a limit of detection (LOD) as low as 0.1 µM (17 ng mL-1) was determined 
(see Figure S7). The calculated LOD indicates the noteworthy sensitivity of the probe, and 
confers our system a competitive basis to detect 5-HT at relevant clinical concentrations. In 











blood serum can be indicative of carcinoid tumours, while values above 1,000 ng mL-1 are 
indicative of metastasis [58-62]. Other studies have found that 5-HT rises from a mean value of 
767 ng mL-1 for those patients with carcinoid tumours to 1,720 ng mL-1 for the patients with 
carcinoid tumours who are also affected by heart disease [63]. Given the importance of 
determining the 5-HT concentration in blood serum, further studies into the response of probe 1 
in simulated blood serum [40] were carried out. Probe 1 in simulated serum showed similar 
behaviour as described above in water when increasing amounts of 5-HT were added (see the 
Supplementary Data). From the A605/A521 vs 5-HT concentration plots, a linear response in 
simulated serum within the 0 to 3 µM 5-HT concentration range was observed, and a LOD of 
0.12 µM (23 ng mL-1) was determined in this medium, which was lower than the normal range 
for adults of 50-300 ng mL-1 (0.28 to 1.70 µM) in blood [64-65]. Finally, encouraged by these 
results, we decided to test the performance of nanoparticles 1 in real human blood samples. 
Samples were taken from a healthy volunteer, and were centrifuged to remove red blood cells 
and proteins (see the Experimental section and Figure S13 for details). Nanoparticles were 
stable in serum samples and led to a change that was observed by the naked eyed when serum 
was spiked with 1 mM of 5-HT (see Figure S14 A). A remarkably significant increase in the 
A605/A521 values was observed from normal serum to serum containing 10 μM of 5-HT (indicative 











Figure 3. a) Colorimetric visualisation of probe 1 when 5-HT was added at concentrations of 0, 0.9, 10, 20, 30, 40, 50, 
70, 100 µM (1-9, respectively). b) Changes in the UV-Vis spectra of probe when 5-HT was added at concentrations of 0, 
0.9, 10, 20, 30, 40, 50, 70, 100 µM. Inset: plot of the A605/A521 vs. 5-HT concentrations within the 0-1 µM range. c) TEM 
images of 1 with 0, 40 and 150 µM of 5-HT, respectively. Experiments were performed at a buffered pH 7.0 (Tris, 50 
mM). 
 
4. Conclusions  
In summary, we report herein a new method for the colorimetric detection of 5-HT using 
15 nm AuNPs bifunctionalized with dithiobis(succinimidylpropionate) and N-acetyl-L-cysteine. 
The prepared nanoparticles, 1, selectively detect 5-HT in water at pH 7 (Tris, 50mM) via the 5-
HT-induced aggregation of the bifunctionalised AuNPs which results in a remarkable colour 
change. The probe is selective to 5-HT and no colour modulation was observed in the presence 
of other neurotransmitters (i.e. dopamine, epinephrine, norepinephrine) and selected 
biomolecules (i.e. L-tyrosine, gamma-aminobutyric acid, L-cysteine, uric acid, oxalic acid, 
aspartic acid and glutamic acid). A linear response within the 0-1 µM 5-HT concentration range 











response of probe 1 to 5-HT was observed in simulated blood serum with a linear response 
within the 0-3 µM 5-HT concentration range and with a LOD as low as 0.12 µM. Finally, the 
probe was capable of detecting 5-HT in human blood samples and of distinguishing between 
normal 5-HT levels and 5-HT levels that are indicative of disease. Given the importance of 
serotonin in different diseases, we expect that our findings could help to elucidate the role 
played by serotonin and to develop innovative tools for early point-of-care or personalised 
diagnosis applications. 
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